Company Profile
Moleculin Biotech, Inc. Stock Price, News & Analysis
- Ticker:
- MBRX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Moleculin Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
2.75 USD (-11.86%)
Close
Last updated: June 23, 2026 at 00:00
14.67M USD
Market cap
Why the stock is moving
MBRX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Moleculin Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Moleculin Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Moleculin Biotech follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Moleculin Biotech sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Moleculin Biotech, Inc. (MBRX)?
Moleculin Biotech, Inc. (MBRX) most recently closed at 2.75 USD, a -11.86% move versus the previous session.
What is the market cap of Moleculin Biotech, Inc. (MBRX)?
Moleculin Biotech, Inc. currently has a market capitalization of 14.67M USD on BioPharmSignal.
What does Moleculin Biotech, Inc. do?
Moleculin Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is MBRX stock listed?
Moleculin Biotech, Inc. (MBRX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Moleculin Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Moleculin?
Moleculin Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Moleculin Biotech, Inc. targeting with Moleculin?
Moleculin Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biotech?
Moleculin Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.